Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Rhythm Biosciences Limited has announced the issue of 4 million unlisted ordinary shares, with a vesting period where 50% will vest 12 months from the issue date and the remaining 50% after 24 months. This move, detailed in the company’s latest Appendix 3G filing dated May 27, 2024, aims to expand the company’s equity base under an employee incentive scheme.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.
